Search

Champions Oncology Inc

Chiusa

SettoreSettore sanitario

4.98 -1.97

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

4.98

Massimo

5.26

Metriche Chiave

By Trading Economics

Entrata

241K

-426K

Vendite

1.4M

15M

P/E

Media del settore

35.118

56.432

EPS

-0.03

Margine di Profitto

-2.797

Dipendenti

214

EBITDA

79K

-95K

Dividendi

By Acuity

Utili prossimi

14 dic 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-4M

68M

Apertura precedente

6.95

Chiusura precedente

4.98

Notizie sul Sentiment di mercato

By Acuity

50%

50%

115 / 339 Classifica in Healthcare

Champions Oncology Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

18 set 2026, 20:02 UTC

Champions Oncology Inc shares fell slightly, continuing a downward trend since Thursday, despite an early recovery during Friday's trading session.

17 set 2026, 20:01 UTC

News

Champions Oncology reported record annual revenue of $59.4 million for fiscal 2026, with shares trading higher amid a positive adjusted EBITDA of $1.6 million.

16 set 2026, 19:06 UTC

Champions Oncology Inc is trading higher, experiencing significant volatility with a sharp midday rise after an initial dip, contrasting with three prior sessions that closed lower.

15 set 2026, 20:03 UTC

News

Champions Oncology reports a net loss of $426,000 and revenue of $15.2 million. Shares are lower amid broader market declines following weak manufacturing data.

11 set 2026, 19:56 UTC

News

Champions Oncology reported Q1 fiscal 2027 revenue of $15.2 million. Shares are lower despite improved gross margin and adjusted EBITDA of approximately $700,000.

10 set 2026, 20:01 UTC

Champions Oncology Inc shares are higher today, continuing upward momentum after three consecutive sessions of decline. The stock remains above its 20-day moving average.

9 set 2026, 20:07 UTC

Champions Oncology Inc shares declined for a fourth straight day, reaching a session low earlier. No specific news was identified to explain the movement.

8 set 2026, 20:13 UTC

Champions Oncology Inc shares are lower in after-market hours, continuing a trend of declining performance over the past three sessions.

4 set 2026, 19:07 UTC

Champions Oncology Inc is trading lower after reversing early gains, reflecting a decline since Thursday's close amid unchanged unemployment rates and decelerating wage growth.

3 set 2026, 20:01 UTC

Champions Oncology Inc shares are higher today, maintaining strong upward momentum since Wednesday's close, despite no specific news to explain the movement.

2 set 2026, 20:08 UTC

Champions Oncology Inc shares are higher today, breaking from a recent pattern of daily gains. No specific news was identified to explain the movement.

28 ago 2026, 19:36 UTC

Champions Oncology Inc. shares are trading roughly flat, with no specific news identified. The stock remains near the lower end of its one-month range.

27 ago 2026, 20:03 UTC

Champions Oncology shares are higher Thursday, reflecting a broader market trend amid declining initial jobless claims reported by the Labor Department.

25 ago 2026, 19:16 UTC

Champions Oncology Inc. is trading higher today, despite a flat performance and remaining below its 20-day moving average. No specific news was identified.

24 ago 2026, 20:06 UTC

News

Champions Oncology reports gross revenue of $59.42 million, with shares declining since Friday's close despite an earlier session increase.

21 ago 2026, 20:06 UTC

Champions Oncology Inc shares are lower in Friday's session amid broader market declines, with no specific news identified to explain the volatility.

20 ago 2026, 19:31 UTC

Champions Oncology Inc is higher today, driven by gains in the Life Sciences Tools & Services sub-sector, despite earlier session declines.

19 ago 2026, 20:02 UTC

Champions Oncology Inc shares declined during Wednesday's session, reaching a low in late morning amid no specific news to explain the downturn.

18 ago 2026, 19:41 UTC

Champions Oncology Inc shares are higher today, despite no specific news. Broader market concerns include inflation and rising treasury yields affecting investor sentiment.

17 ago 2026, 19:36 UTC

Champions Oncology Inc's shares are higher during Monday's session, reflecting a modest increase since Friday's close. The stock remains below its 20-day moving average.

14 ago 2026, 20:02 UTC

Champions Oncology is trading lower, reflecting broader market sentiment amid a surprising decline in U.S. retail sales for July.

13 ago 2026, 19:26 UTC

Champions Oncology Inc shares are higher during Thursday's session, rebounding from an earlier dip despite remaining below the 20-day moving average.

12 ago 2026, 19:51 UTC

Champions Oncology Inc's shares are lower today, diverging from recent gains, with no specific news identified to explain the decline.

11 ago 2026, 19:41 UTC

Champions Oncology Inc shares are lower today amid no specific news. The stock remains below its 20-day moving average and near the month's low.

10 ago 2026, 19:31 UTC

Champions Oncology Inc shares are lower, continuing a decline since Friday's close. The stock remains near its one-month range's lower end.

7 ago 2026, 19:42 UTC

Champions Oncology Inc shares are higher, driven by gains in the Life Sciences Tools & Services sub-sector. Earlier, they pulled back from a session high.

6 ago 2026, 19:32 UTC

Champions Oncology Inc shares are lower, continuing a downward trend amid broader market concerns over inflation and Federal Reserve policy. No specific news was identified.

5 ago 2026, 19:31 UTC

Champions Oncology Inc shares are lower during Wednesday's session, reflecting significant volatility amid broader market conditions and a notable drop in crude oil prices.

4 ago 2026, 19:51 UTC

Champions Oncology Inc shares are lower today, influenced by a decline in the Life Sciences Tools & Services sub-sector. The stock remains below its 20-day moving average.

3 ago 2026, 20:13 UTC

Champions Oncology Inc shares are trading higher in after-market hours. Broader market momentum is supported by strong tech performances and positive sentiment ahead of economic data.

Confronto tra pari

Modifica del prezzo

Champions Oncology Inc Previsione

Consenso sulla valutazione

By TipRanks

0 ratings

0

Acquista

0

Mantieni

0

Vendi

Sentiment

By Acuity

115 / 339 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Neutral

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Champions Oncology Inc

Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.